New Releases from NCBI BookshelfEvidence reviews for vitrectomy: Diabetic retinopathy: management and monitoring: Evidence review F.Evidence reviews for vitrectomy: Diabetic retinopathy: management and monitoring: Evidence review F.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfEvidence reviews for the effectiveness and acceptability of anti-vascular endothelial growth factor agents and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy: Diabetic retinopathy: management and monitoring: Evidence review E.Evidence reviews for the effectiveness and acceptability of anti-vascular endothelial growth factor agents and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy: Diabetic retinopathy: management and monitoring: Evidence review E.
Post Content
Uncategorized
New Releases from NCBI BookshelfEvidence reviews for effectiveness of intensive treatments to lower blood glucose levels on progression of diabetic retinopathy and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review C.Evidence reviews for effectiveness of intensive treatments to lower blood glucose levels on progression of diabetic retinopathy and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review C.
Post Content
Uncategorized
New Releases from NCBI BookshelfShared Decision Making Coaching for Behavioral Health Providers and Patients [Internet].Shared Decision Making Coaching for Behavioral Health Providers and Patients [Internet].
Shared decision-making (SDM) in health care is a process in which both patients and providers are equal partners collaborating to
Uncategorized
New Releases from NCBI BookshelfAging in Place: Appropriate Use Recommendation [Internet].Aging in Place: Appropriate Use Recommendation [Internet].
Canada is experiencing an important demographic transition toward an increasingly diverse aging population with an increased need for care and
Uncategorized
New Releases from NCBI BookshelfEtrasimod (Velsipity): Indication: For the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or an advanced treatment: CADTH Reimbursement Recommendation [Internet].Etrasimod (Velsipity): Indication: For the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or an advanced treatment: CADTH Reimbursement Recommendation [Internet].
CADTH recommends that Velsipity be reimbursed by public drug plans for the treatment of adults with moderately to severely active
Uncategorized
New Releases from NCBI BookshelfLong-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection.Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection.
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in early 2020, many individuals infected with the virus that
Uncategorized
New Releases from NCBI BookshelfComparing Two Methods to Improve CPAP Use among Patients with COPD and Obstructive Sleep Apnea — The O2VERLAP Study [Internet].Comparing Two Methods to Improve CPAP Use among Patients with COPD and Obstructive Sleep Apnea — The O2VERLAP Study [Internet].
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are 2 major chronic conditions that affect millions of Americans.
Uncategorized
New Releases from NCBI BookshelfCabotegravir (Apretude): Indication: For at-risk adults and adolescents aged 12 years and older and weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection: CADTH Reimbursement Recommendation [Internet].Cabotegravir (Apretude): Indication: For at-risk adults and adolescents aged 12 years and older and weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection: CADTH Reimbursement Recommendation [Internet].
CADTH recommends that Apretude should be reimbursed by public drug plans for at-risk adults and adolescents aged 12 years and
